Advertisement

Germany: GNA Biosolutions raises US$13.5m Series C

Munich-based molecular diagnostics company GNA Biosolutions has completed US$13.5m Series C funding. New investors including GreyBird Ventures, Occident, and Wachtumsfonds Bayern joined the round as...

India: SuVitas raises funds for expansion

Hyderabad-based SuVitas, a provider of inpatient transition care facilities, has closed an undisclosed round of funding from a group of investors led by Axon...

France: Tissium closes €38.75m Series B

Wound treatment developer Tissium has raised €38.75m (US$42.8m) Series B funding to support the company’s expansion globally, particularly in the fields of nerve repair,...

Sweden: KRY raises US$155m Series C

Swedish digital healthcare provider KRY has raised US$155m in Series C funding to support its plans for further expansion in Europe. It is one...

Hong Kong: Hygeia Healthcare to raise up to US$500m in IPO

Warburg Pincus-backed Hygeia Healthcare, the largest oncology healthcare group in China, is looking to raise up to US$500m in an initial public offering in...

Sweden: IRRAS to raise SKr217m in rights issue

Swedish medtech company IRRAS is to raise SKr217m (US$22.3m) in a fully underwritten rights issue to help commercialise its products. It is selling 37.5 million...

Spain: MAPFRE launches 3% bond for healthcare equipment

Spanish insurance company MAPFRE has launched a three-year 3% guaranteed mutual fund with a bond issued by the Madrid local government to finance the...

MENA: Humania raises US$125m Islamic financing facility for hospital development

Humania, a private healthcare company within the Bait Al Batterjee Group, has completed a US$125m Islamic financing facility to develop hospitals in Egypt and...

Belgium: Aedifica reports 89% take up of capital increase

Belgian healthcare REIT Aedifica has reported an 89% take up on its €418m (US$469m) rights issue. The company said that 5.5m shares had been taken...

Spain: Banco Sabadell sells 40% of Ribera Salud Centene

Banco Sabadell has sold its 40% stake in Ribera Salud to Centene for €60m (US$67.4m). The NYSE-listed healthcare corporation now owns a 90% stake...